Swiss Biotechs display their innovations at BIO 2022 International Convention

The swisstech pavilion at BIO 2022 in San Diego features 21 leading Swiss startups focussing on therapeutics as well as tools and services based on AI or micro-gravity. The event gives companies the platform to showcase their innovations and network with a global audience to forge partnerships or attract investors and customers.

After a successful online event last year – with over 6,000 participants from at least 55 countries – this year’s conference takes place on-site in San Diego, California, from June 13-16. Under the theme LIMITLESS, the BIO International Convention brings together players in the biotechnology sector to connect, learn and present their innovations. Companies will also have the opportunity to discuss their pipeline, R&D activities, and future fundraising goals with potential investors and partners.

Switzerland brings a delegation of startups and ecosystem players showcasing the country’s innovative strength at the swisstech pavilion which is organised by Switzerland Global Enterprise and Presence Switzerland in collaboration with the Swiss Biotech Association, Innosuisse, swissnex and digitalswitzerland.

Nine of the startups travelling to San Diego, California, will receive support from Innosuisse, the Swiss Innovation Agency. The companies cover all aspects of the drug discovery and development chain, from omics data crunching to AI-driven trial design.

Startups sponsored by Innosuisse are:

BigOmics – self-service omics data analysis platforms

CDR-Life –tumour-specific antibody therapeutics

Cellestia Biotech – cancer gene therapies

Cellvie – therapeutic mitochondria transplantation

FluoSphera – human cell-based drug development assays

MV BioTherapeutics – microbiome biotherapeutics

Risklick – AI-driven clinical trial design

Synendos – neuropsychiatric therapeutics

ZuriMED Technologies – soft tissue repair

Others exhibiting startups are

Elthera AG – precision medicine oncology

interAx Biotech AG – experimental and computational intelligent drug design 

Healiva – precision solutions for chronic wounds

leadXpro – membrane proteins for drug discovery

SpacePharma - microgravity (virtual weightlessness) for R&D

ten23 health AG – human-centric and sustainable strategic partner of choice

Novochizol SA – chitosan-based drug formulation, first-in-class polysaccharide nanospheres

Gadia SA - rapid in vitro diagnostic (IVD) test to detect nosocomial diseases

Ceidos SA – automated system for continuously monitoring cell density

Rem Analytics – Targeted genetic analysis: Advanced testing for genetic composition

YONI Solutions – better results in vaginal microbiome analysis, linked to the fertility of women

Excellgene –smart science and innovative cell line development

In addition to the start-ups a group of support organisations and service providers will be exhibiting at the pavilion. These include:

BioAlps Association – NPO and Life Sciences Cluster of Western Switzerland

Biopôle SA – innovation-oriented life sciences, brings together industry and academics

KPMG AG – specialisation in audit, tax, advisory, financial services and legal

Venture Valuation / Biotechgate – asset and company valuations in the life sciences industry

Wyss Zurich Translational Center – joint research and development center

(RAN / SK)